Unlike traditional MEA recordings that can only measure field potentials, the IntraCell uses a laser to precisely optoporate cardiomyocytes underneath each electrode.
Wildfire smoke poses a growing public health threat, with harmful pollutants like PM2.5 linked to respiratory and cardiovascular issues. This blog explores the health impacts of wildfire smoke, highlights recent research advancements, and showcases innovative tools like DSI’s inhalation exposure systems and telemetry solutions. Discover how these technologies are helping researchers uncover the mechanisms behind smoke-related health risks and develop interventions to protect vulnerable populations.
The integration of behavioral telemetry and organoid research is transforming neuroscience and biomedical science by linking cellular models with complex biological behaviors.
Revolutionize your diabetes research with DSI’s continuous glucose telemetry system. This innovative technology enables real-time, long-term glucose monitoring in animal models, offering stress-free, comprehensive data collection. By bridging preclinical and clinical research, it supports breakthroughs in glycemic control and translational therapies. Learn how it’s shaping the future of diabetes treatments.
Organoid technology is poised to revolutionize the development of brain-controlled prosthetics. By bridging the gap between the body’s central nervous system and a synthetic device, research with neural organoids could lead to the development of prosthetics capable of real-time interaction with the human brain through closed-loop feedback systems. Multielectrode array technology (also called “microelectrode array” or “MEA”) from Multi Channel Systems is ideally suited for studying this complex interaction and developing innovations in prosthetic research.
PTSD affects millions, with varied trauma responses complicating treatment. Advanced research tools, including telemetry and behavioral systems, help uncover physiological and behavioral insights, paving the way for personalized therapies. Studies highlight sex-specific stress adaptations, novel drug targets, and physiological biomarkers, advancing understanding and treatment options for this complex disorder. Continued innovation is key to improving PTSD care.
Lung fibrosis is a serious condition that limits lung function, and traditional research methods often rely on invasive techniques. However, Whole Body Plethysmography (WBP) offers a noninvasive solution for tracking fibrosis progression over time. This method allows researchers to monitor lung function in animal models without terminal procedures, providing valuable insights for developing effective treatments and understanding disease development.
Unlock the future of Alzheimer’s research with groundbreaking lab tools from Harvard Bioscience. This video showcases how our cutting-edge technologies, including BTX's electroporation systems, Biochrom's molecular analysis tools, and advanced electrophysiology solutions, accelerate discoveries in Alzheimer’s disease. From gene therapy to live cell imaging and cognitive testing in animal models, watch how Harvard Bioscience is building labs to advance Alzheimer’s research and equip the next generation of scientists with tools that could lead to life-changing breakthroughs.
Microelectrode arrays – also known as “multielectrode arrays” or MEAs – are powerful tools used in neuroscience, cardiac research, and pharmacology to study the electrical activity of excitable tissues like neurons and cardiac cells. But what exactly is an MEA system, and how do they work?
Harvard Bioscience is gearing up to showcase its latest innovations at the Society for Neuroscience (SfN) 2024 meeting, happening from October 5-9 in Chicago, IL.
